$SLDE

Insider Selling: Slide Insurance (NASDAQ:SLDE) Director Sells 2,437 Shares of Stock

Slide Insurance Holdings director Beth Witte Bruce sold 2,437 shares on May 22 at an average $18.70, for about $45,571.90, according to an SEC filing. After the sale, she held 224,208 shares. The article also notes prior sales in May. It cites Q1 results: $1.02 EPS vs $0.82 consensus on $389.28M revenue, plus a $100M share repurchase authorization.

Original reporting
Published May 28, 2026, 3:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 28, 2026, 4:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Insider Selling: Slide Insurance (NASDAQ:SLDE) Director Sells 2,437 Shares of Stock — source image
Decision brief

The 30-second read

$SLDENeutralMed
01

Why it matters

Insider selling can create short-term negative optics, but the presence of a board repurchase program and the lack of new negative operating information suggest the effect may be muted.

02

Market read

Traders may reassess SLDE sentiment on the back of insider trimming, but the dominant near-term catalysts remain earnings trajectory and buyback execution.

03

What to watch

The article notes multiple prior director sales and a recent earnings beat; traders should check whether selling clusters around specific dates/lockups and whether buybacks are actually executed at scale.

Relevance 7/10Timing: Immediate (fresh SEC-disclosed insider sale; may affect short-term positioning).

Background

The piece reports SEC-disclosed director selling and summarizes recent company fundamentals (earnings beat, buyback authorization) and analyst/institutional activity.

Company-level read

Ticker impact

$SLDENeutralMedium confidence
Context

Slide Insurance director Beth Witte Bruce sold 2,437 shares at an average $18.70, reducing her stake by 1.08% per SEC disclosure.

Expected impact

Likely limited downside pressure unless follow-on selling accelerates or broader fundamentals deteriorate.

Evidence & confidence

The article is a Form 4-style ownership change with specific sale sizes and prices, but it provides no new earnings/guidance or operational catalyst beyond prior repurchase authorization and recent earnings beat.

Market effects

For specialty P&C insurers, insider selling can modestly affect sentiment, but buyback authorization and underwriting profitability remain the primary drivers.

No specific regional regulatory/catastrophe catalyst is cited; impact is company-specific sentiment rather than coastal-insurance read-through.

Minimal global relevance; the news is an SEC insider transaction for a US-listed insurer.

Counterpoint

The director’s sales could be routine diversification or liquidity-driven; the company simultaneously authorized a sizable $100M repurchase program.

Key entities

  • Slide Insurance Holdings, Inc.

    NASDAQ-listed specialty insurer; director Beth Witte Bruce sold shares and the board authorized a $100M repurchase program.

Related articles

$SLDEMed

Slide Insurance Q2 Earnings Call Highlights

Slide Insurance (NASDAQ:SLDE) reported Q2 expense ratio of 27.4% versus 30% a year earlier, and guided it near 28% (range 28% to 30%). For first six months of 2026, it posted 56.5% combined ratio and 23.8% ROE. It completed a 2026 catastrophe reinsurance program, expanded capacity, launched in California, and received approvals for RI and NJ. It repurchased ~3M shares at $17.95, declared a $0.07 dividend, and reaffirmed 2026 guidance: $1.85B-$1.95B gross premiums and $455M-$470M net income.

$SLDEHigh

Slide Insurance Holdings, Inc. (SLDE): Results of Operations and Financial Condition

Slide Insurance Holdings, Inc. (SLDE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 slde-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SLIDE REPORTS SECOND QUARTER 2026 RESULTS - Gross Premiums Written Grew 16.7% Year-over-Year to $508.0 Million - - Net Income Increased 92.4% Year-over-Year to $134.9 Million; $1.06 Diluted Earnings Per Share - - Combined Rat

$MCDMedAI 8/10

McDonald’s outlines $8.5 billion plan to support franchisees

McDonald's announced an $8.5 billion investment in its 'NEXT' strategy to support franchisees, aiming for margin and market share growth. The plan includes rent relief and capital support, with targets for unit expansion and operating margins. The company also appointed Skye Anderson as U.S. president to drive its turnaround strategy. McDonald's reported slower sales growth due to inflation and competition, missing U.S. sales growth estimates in Q2.

$ARTLMedAI 8/10

Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings

Artelo Biosciences (ARTL) filed a provisional patent for ART27.13, showing 20% weight loss as monotherapy and 40% with semaglutide in obese mice. The study also found improved glucose tolerance and bone density. The company aims to expand ART27.13's use in obesity, a market projected to reach $200B by 2030.